Owkin
About Owkin
Owkin is a life sciences technology company that develops agentic AI to accelerate biomedical research, drug discovery, development, and diagnostics. It leverages multimodal patient data and diverse biological samples from academic partners to power its AI insights, aiming to reveal causal relationships and actionable findings across biology. The company operates globally with data networks and software platforms like K Pro to drive decision-making across pharma, diagnostics, and research teams.
Recent News
GV-Backed Biotech Startup OMass Faces IP Lawsuit
London-Based Geordie AI Secures €25 Million to Help Enterprises Govern AI Agents
Modern Relay Raises $3M to Build Shared Infrastructure Layer for AI Agents in the Enterprise
AI Needs a Reality Check
Owkin Unveils Biology-Focused AI Agents for Clinical Research and Drug Discovery
Geordie Raises $30M to Help Enterprises Securely Adopt Agentic AI at Scale
An ‘AI Scientist’ Can Tackle Drug R&D. What Does that Mean for Pharma?
Recent Deals
No recent deals for this company.